Burkehill Global Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Burkehill Global Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-150,000	Closed	-$5.96M	–	181
2026 Q1	$5.96M	Hold	150,000	–	–	0.3%	68
2025 Q4	$3.75M	Buy	+150,000	New	+$3.8M	0.25%	91

Burkehill Global Management's CNTA Position: Q2 2026 in Review

Burkehill Global Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 150,000 shares — an estimated $5.96M sold.

Burkehill Global Management first reported a position in CNTA in Q4 2025 and held it in 2 quarters. The position peaked at $5.96M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Burkehill Global Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Burkehill Global Management sold 150,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $5.96M.
Burkehill Global Management first reported a position in Centessa Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Burkehill Global Management's Centessa Pharmaceuticals position peaked at $5.96M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.